Skip to main content
Premium Trial:

Request an Annual Quote

Roche H1 Earnings, Replacement of CEO Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, July 20.
 
1. Roche Molecular Dx Sales Slip in H1; Unit's Chief Tapped to Replace Company CEO (from July 19)
 
2. Quest to Outfit Labs With Bio-Rad's BioPlex 2200 Platform, HIV Assay (from July 17)
 
3. FDA Clears Veridex's Gene-Based Lymph Node Assay for Breast Cancer Metastasis (from July 18)
 
4. George Mason to Combine Proteomics and Biodefense Chops to Study Infectious Diseases (from July 17)
 
5. Febit Sues Codon for Infringing Polymer Synthesis IP; Codon Says Patent is 'Invalid and Unenforceable' (from July 16)
The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.